Biologically Active Heteroglycoclusters Constructed on a Pillar[5]arene-Containing [2]Rotaxane Scaffold.
about
Glycomaterials for probing host-pathogen interactions and the immune response.Toward the Rational Design of Galactosylated Glycoclusters That Target Pseudomonas aeruginosa Lectin A (LecA): Influence of Linker Arms That Lead to Low-Nanomolar Multivalent Ligands.Sugared biomaterial binding lectins: achievements and perspectives.Biological and related applications of pillar[n]arenes.Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity.The aqueous supramolecular chemistry of cucurbit[n]urils, pillar[n]arenes and deep-cavity cavitands.Potent Glycosidase Inhibition with Heterovalent Fullerenes: Unveiling the Binding Modes Triggering Multivalent Inhibition.Phosphonium pillar[5]arenes as a new class of efficient biofilm inhibitors: importance of charge cooperativity and the pillar platform.Pentavalent pillar[5]arene-based glycoclusters and their multivalent binding to pathogenic bacterial lectins.Synthesis of a New Series of Sialylated Homo- and Heterovalent Glycoclusters by using Orthogonal Ligations.Coordination-Driven Folding in Multi-ZnII -Porphyrin Arrays Constructed on a Pillar[5]arene Scaffold.The Impact of Heteromultivalency in Lectin Recognition and Glycosidase Inhibition: An Integrated Mechanistic Study.A Rotaxane Scaffold for the Construction of Multiporphyrinic Light-Harvesting Devices.Fullerene hexa-adduct scaffolding for the construction of giant molecules.A Rotaxane Scaffold Bearing Multiple Redox Centers: Synthesis, Surface Modification and Electrochemical Properties.Mechanistic Insight into Heptosyltransferase Inhibition by using Kdo Multivalent Glycoclusters.Preparation of Pillar[5]arene-Based [2]Rotaxanes by a Stopper-Exchange Strategy.Pillar[5]arene-Based Glycoclusters: Synthesis and Multivalent Binding to Pathogenic Bacterial Lectins.
P2860
Q37107154-55374A2D-EBC2-4FF9-B79C-110DEE9FA3FBQ38291727-A51A213D-0931-4F50-95AB-346192C6AF57Q38807532-1D4FBE00-557B-4ABC-8044-AED2578B00B6Q39036046-F9F45384-C67C-4F1D-856E-3FC6B8210325Q39192653-F50901E1-B4D5-4D5E-A992-23C8614122D2Q39198168-B5DA8880-4A77-478C-A530-B51672DBF23AQ39635191-C5BDE99A-A18F-4265-9D35-AF3630BF0E77Q40583513-57FFE23B-7BA2-4AC0-A142-7ED0B4448401Q40757552-98F777A1-C46E-4CB6-80FD-5C5C1D01DD5EQ41446300-971D6F50-BD29-49C9-8388-BA7AB510A2C4Q46377874-7690273C-FEA8-4E98-8872-162DC60C0293Q46412085-1024DB14-FDF6-42BB-9022-0259477A08E8Q47431311-0C282B0A-4390-4D4E-BABE-AA4660290BEFQ47606457-C15B9F1C-0A5C-43A1-9160-942001DEFC02Q48047226-A59CAA69-5B90-4B85-B07A-E329C81F801BQ48115657-6A547C4F-7FB3-47B9-AE2F-ED9B683BCB83Q48124094-88051984-FB49-45A2-A084-7FDFD8B535C0Q48246643-79BE5FE8-4D44-4551-8E98-53FD3897A409
P2860
Biologically Active Heteroglycoclusters Constructed on a Pillar[5]arene-Containing [2]Rotaxane Scaffold.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biologically Active Heteroglyc ...... ntaining [2]Rotaxane Scaffold.
@en
type
label
Biologically Active Heteroglyc ...... ntaining [2]Rotaxane Scaffold.
@en
prefLabel
Biologically Active Heteroglyc ...... ntaining [2]Rotaxane Scaffold.
@en
P2860
P50
P356
P1476
Biologically Active Heteroglyc ...... ntaining [2]Rotaxane Scaffold.
@en
P2093
Kevin Buffet
Stéphane P Vincent
P2860
P356
10.1002/CHEM.201504110
P407
P577
2015-10-15T00:00:00Z